This federal contract award, valued at $4,303.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the medication Trelegy Ellipta, a combination inhaler used for the treatment of chronic obstructive pulmonary disease (COPD).
The contract has an ultimate completion date of November 21, 2024 and utilizes a firm fixed price pricing type. This award is not associated with a set-aside program.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/19/25, 9:13 AM